This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Medical University of Vienna. Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2019
Title: Johannes Hofer: Innovator in Pharmaceutical Composition
Introduction
Johannes Hofer is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of inflammatory conditions. With a total of 2 patents, his work has the potential to impact medical treatments significantly.
Latest Patents
Hofer's latest patents focus on the complement split product C4d for the treatment of inflammatory conditions. The first patent describes a pharmaceutical composition comprising complement split product C4d for use in treating various inflammatory conditions, such as graft rejection, graft versus host disease, autoimmune diseases, or atopy. The invention emphasizes the use of C4d multimers and their application in medicine. Additionally, it introduces a protein complex comprising C4d interacting with its ILT4 receptor, which may be utilized in screening methods. The patent also covers antibodies that specifically bind to the C4d multimer or the C4d/ILT4-protein complex.
Career Highlights
Throughout his career, Johannes Hofer has worked with esteemed institutions, including the Medical University of Vienna and the Research Center Pharmaceutical Engineering GmbH. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Hofer has collaborated with notable colleagues, including Peter Steinberger and Gerhard Zlabinger. These partnerships have likely enriched his research and development efforts in the pharmaceutical field.
Conclusion
Johannes Hofer's contributions to pharmaceutical compositions, particularly in treating inflammatory conditions, highlight his innovative spirit and dedication to advancing medical science. His patents and collaborations reflect a commitment to improving healthcare outcomes through research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
